Mauricio Pasquale
Physician Assistant · Eldon, MONPI 1609170018
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Arthrex at 48.1% of the total. Reporting peaked in 2021 at $2,300 and has fallen 95.4% since, to $106 in 2025.
Across 50 payments — averaging $58.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Elite Orthopedics, LLC$807
- Kowa Pharmaceuticals America, Inc.$121
- AbbVie$77
- Teva Pharmaceuticals USA, Inc.$64
- Lundbeck LLC$63
- plus $388 from 15 others
What the payments were for
- Travel & lodging$87830%
- Food & beverage$85529%
- Education$1,20041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 3 | $1,412 |
| Elite Orthopedics, LLC | 7 | $807 |
| Kowa Pharmaceuticals America, Inc. | 6 | $121 |
| AbbVie | 4 | $77 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Lundbeck LLC | 4 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| Heron Therapeutics, Inc. | 2 | $42 |
| Amgen | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Organogenesis Inc. | 2 | $30 |
| Pacira Therapeutics, Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Davol Inc. | 1 | $23 |
| AstraZeneca | 1 | $19 |
| Merck | 1 | $18 |
| Stryker | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Exact Sciences | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,933 in reported general payments places this provider in the 85th percentile of 1,380 physician assistant providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PaxlovidNirmatrelvir/Ritonavir | 31 | $4,249 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 79 | $1,461 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 174 | $1,246 |
| Doxycycline Hyclate | 142 | $977 |
| Cephalexin | 126 | $719 |
| Methylprednisolone | 109 | $655 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 13 | $628 |
| Ofloxacin | 11 | $612 |
| Azithromycin | 117 | $465 |
| Cefdinir | 28 | $462 |
| Prednisone | 272 | $356 |
| MoxifloxacinMoxifloxacin Hcl | 14 | $348 |
| Fluticasone Propionate | 22 | $210 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 53 | $200 |
| Triamcinolone Acetonide | 38 | $146 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Eldon
- Jennifer DavissonKansas City$343K
- Andrew BergLees Summit$245K
- Sileen DowisKansas City$117K
- Daniel BeckSikeston$114K
- Amee RozancO Fallon$101K
- Autumn WillsCape Girardeau$37K
- Kimberly BrownSaint Louis$28K
- Marc ReitznerSpringfield$24K
- Justin AllphinOzark$23K
- Jacqueline CastagnoWentzville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.